Vivos Therapeutics, Inc. Earnings Per Share (Basic)
Vivos Therapeutics, Inc. (VVOS) reported Earnings Per Share (Basic) of -$0.31 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- Vivos Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.31.
- Vivos Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.52.
- Vivos Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.56.
- Vivos Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.49.
- Vivos Therapeutics, Inc. earnings per share, basic for fiscal 2025 was -$2.07.
- Vivos Therapeutics, Inc. earnings per share, basic for fiscal 2024 was -$2.22.
- Vivos Therapeutics, Inc. earnings per share, basic for fiscal 2023 was -$11.14.
- Vivos Therapeutics, Inc. earnings per share, basic for fiscal 2022 was -$25.90.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.31 10-Q · filed 2026-08-14 | -$0.81 10-Q · filed 2026-08-14 | -$1.35 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.83 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2026-03-31 | -$0.52 10-Q · filed 2026-05-20 | -$1.08 derived: net income ÷ weighted average shares · filed 2026-05-20 | -$1.58 derived: net income ÷ weighted average shares · filed 2026-05-20 | -$2.13 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-12-31 | -$0.56 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$1.06 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$1.60 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$2.07 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | -$0.49 10-Q · filed 2025-11-19 | -$1.04 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.49 10-Q · filed 2025-11-19 | -$1.91 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-06-30 | -$0.55 10-Q · filed 2026-08-14 | -$1.00 10-Q · filed 2026-08-14 | -$1.41 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.82 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-03-31 | -$0.45 10-Q · filed 2026-05-20 | -$0.85 derived: net income ÷ weighted average shares · filed 2026-05-20 | -$1.24 derived: net income ÷ weighted average shares · filed 2026-05-20 | -$1.75 derived: net income ÷ weighted average shares · filed 2026-05-20 | ||||
| 2024-12-31 | -$0.39 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.79 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$1.30 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$2.22 10-K · filed 2026-04-15 | ||||
| 2024-09-30 | -$0.40 10-Q · filed 2025-11-19 | -$0.92 derived: net income ÷ weighted average shares · filed 2025-11-19 | -$1.94 10-Q · filed 2025-11-19 | -$3.70 derived: net income ÷ weighted average shares · filed 2025-11-19 | ||||
| 2024-06-30 | -$0.60 10-Q · filed 2025-08-19 | -$2.06 10-Q · filed 2025-08-19 | -$4.29 derived: net income ÷ weighted average shares · filed 2025-08-19 | -$5.91 derived: net income ÷ weighted average shares · filed 2025-08-19 | ||||
| 2024-03-31 | -$1.63 10-Q · filed 2025-05-15 | -$4.30 derived: net income ÷ weighted average shares · filed 2025-05-15 | -$6.16 derived: net income ÷ weighted average shares · filed 2025-05-15 | -$10.22 derived: net income ÷ weighted average shares · filed 2025-05-15 | ||||
| 2023-12-31 | -$3.00 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$4.85 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$9.34 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$11.14 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$1.75 10-Q · filed 2024-11-14 | -$6.37 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$8.09 10-Q · filed 2024-11-14 | -$13.64 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||||
| 2023-06-30 | -$4.62 10-Q · filed 2024-08-14 | -$0.18 10-Q · filed 2023-08-16 | -$6.40 10-Q · filed 2024-08-14 | -$0.26 10-Q · filed 2023-08-16 | -$12.03 derived: net income ÷ weighted average shares · filed 2024-08-14 | -$17.98 derived: net income ÷ weighted average shares · filed 2024-08-14 | ||
| 2023-03-31 | -$1.72 10-Q · filed 2024-05-14 | -$0.07 10-Q · filed 2023-06-08 | -$7.33 derived: net income ÷ weighted average shares · filed 2024-07-30 | -$13.34 derived: net income ÷ weighted average shares · filed 2024-07-30 | -$3.34 derived: net income ÷ weighted average shares · filed 2024-07-30 | |||
| 2022-12-31 | -$5.37 derived: net income ÷ weighted average shares · filed 2024-07-30 | -$11.62 derived: net income ÷ weighted average shares · filed 2024-07-30 | -$2.39 derived: net income ÷ weighted average shares · filed 2024-07-30 | -$25.90 10-K/A · filed 2024-07-30 | -$1.04 10-K · filed 2023-03-30 | |||
| 2022-09-30 | -$6.40 10-Q · filed 2023-11-14 | -$0.26 10-Q · filed 2022-12-20 | -$1.13 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$20.90 10-Q · filed 2023-11-14 | -$0.84 10-Q · filed 2022-12-20 | -$0.00 derived: net income ÷ weighted average shares · filed 2023-11-14 | ||
| 2022-06-30 | -$0.33 10-Q · filed 2023-08-16 | -$0.58 10-Q · filed 2023-08-16 | -$0.00 derived: net income ÷ weighted average shares · filed 2023-08-16 | -$0.00 derived: net income ÷ weighted average shares · filed 2023-08-16 | ||||
| 2022-03-31 | -$0.25 10-Q · filed 2023-06-08 | -$0.26 10-Q · filed 2022-05-16 | -$0.00 derived: net income ÷ weighted average shares · filed 2023-06-08 | -$0.00 derived: net income ÷ weighted average shares · filed 2023-06-08 | -$0.00 derived: net income ÷ weighted average shares · filed 2023-06-08 | |||
| 2021-12-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.00 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.00 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.96 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | -$0.26 10-Q · filed 2022-12-20 | -$0.00 derived: net income ÷ weighted average shares · filed 2022-12-20 | -$0.62 10-Q · filed 2022-12-20 | |||||
| 2021-06-30 | -$0.19 10-Q · filed 2022-12-20 | -$0.38 10-Q · filed 2022-12-20 | ||||||
| 2021-03-31 | -$0.19 10-Q/A · filed 2022-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |